Q3 2024 Holdings
Filed 2024-11-14 | 141 holdings | $517.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nuveen Churchill Direct Lend(NCDL) | COM SHS | 67090S108 | $70.4M | 4,039,553 | 13.6% |
| Klaviyo Inc(KVYO) | COM SER A | 49845K101 | $42.4M | 1,198,270 | 8.2% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $39.3M | 1,530,401 | 7.6% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $33.7M | 3,004,199 | 6.5% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $33.7M | 2,010,972 | 6.5% |
| Blue OWL Capital Corporation(OBDC) | COM | 69121K104 | $29.8M | 2,045,070 | 5.8% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $27.3M | 4,166,829 | 5.3% |
| Proshares TR(TQQQ) | ULTRAPRO QQQ | 74347X831 | $23.6M | 325,000 | 4.6% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $20.2M | 3,058,969 | 3.9% |
| Evercommerce Inc(EVCM) | COM | 29977X105 | $17.0M | 1,641,929 | 3.3% |
| Acelyrin Inc | COM | 00445A100 | $13.8M | 2,793,946 | 2.7% |
| Conduent Inc(CNDT) | COM | 206787103 | $13.6M | 3,363,022 | 2.6% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $11.6M | 3,372,499 | 2.2% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $10.6M | 5,411,290 | 2.1% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $9.1M | 163,238 | 1.8% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $8.6M | 175,260 | 1.7% |
| Holley Inc(HLLY) | COM | 43538H103 | $7.5M | 2,543,588 | 1.5% |
| E2open Parent Holdings Inc(ETWOGBP) | COM CL A | 29788T103 | $7.3M | 1,650,943 | 1.4% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $7.1M | 122,633 | 1.4% |
| Ikena Oncology Inc | COM | 45175G108 | $7.1M | 4,091,118 | 1.4% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $6.1M | 1,225,000 | 1.2% |
| Inozyme Pharma Inc | COM | 45790W108 | $5.9M | 1,120,027 | 1.1% |
| Lanzatech Global Inc | COM | 51655R101 | $5.6M | 2,926,514 | 1.1% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $5.3M | 2,879,712 | 1.0% |
| CCC Intelligent Solutions HL(CCC) | COM | 12510Q100 | $5.1M | 457,104 | 1.0% |
| Sagimet Biosciences Inc(SGMT) | COM SER A | 786700104 | $4.6M | 1,673,877 | 0.9% |
| Starwood Property Trust(STWD) | SHS | 85571B105 | $4.6M | 226,456 | 0.9% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $4.1M | 1,126,025 | 0.8% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $4.1M | 255,000 | 0.8% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $3.6M | 80,000 | 0.7% |
| Aeon Biopharma Inc | CL A | 00791X100 | $3.5M | 3,341,204 | 0.7% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $3.5M | 847,809 | 0.7% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $2.9M | 65,000 | 0.6% |
| Viking Therapeutics Inc(VKTX)Call | COM | 92686J106 | $2.6M | 41,000 | 0.5% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $2.4M | 196,132 | 0.5% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $2.3M | 733,568 | 0.4% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $2.3M | 80,000 | 0.4% |
| Blend Labs Inc(BLND) | CL A | 09352U108 | $1.4M | 361,587 | 0.3% |
| Payoneer Global Inc(PAYO) | COM | 70451X104 | $1.3M | 208,203 | 0.3% |
| Omega Therapeutics Inc | COMMON STOCK | 68217N105 | $1.3M | 1,055,882 | 0.2% |
| Braze Inc(BRZE) | COM CL A | 10576N102 | $1.3M | 39,111 | 0.2% |
| NU Hldgs LTD(NU) | ORD SHS CL A | G6683N103 | $1.2M | 91,324 | 0.2% |
| Syros Pharmaceuticals Inc(SYRS) | COM NEW | 87184Q206 | $1.1M | 515,855 | 0.2% |
| Enterprise Prods Partners L(EPD) | COM | 293792107 | $910.9K | 31,290 | 0.2% |
| SHF Holdings Inc | CLASS A COM | 824430102 | $834.9K | 1,517,924 | 0.2% |
| Gohealth Inc(GOCO) | CL A NEW | 38046W204 | $781.0K | 83,264 | 0.2% |
| Proshares TR II | ULTRA VIX SHORT | 74347Y755 | $747.9K | 30,000 | 0.1% |
| Engene Holdings Inc(ENGNW) | *W EXP 10/31/202 | 29286M113 | $728.4K | 511,177 | 0.1% |
| Marblegate Acquisition Corp | COM CL A | 56608A105 | $687.0K | 91,429 | 0.1% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $450.1K | 39,003 | 0.1% |